OPRK1 rs963549: What Your Genotype Means
The rs963549 variant is a common genetic change located within the OPRK1 gene, which encodes the kappa-opioid receptor. Research has explored its potential role in individual differences regarding stress-related addiction susceptibility and variations in methadone maintenance dosage requirements.
What each genotype means
Lower methadone dose requirement
Research indicates that individuals with this genotype may require lower daily maintenance doses of methadone compared to those with other genotypes. This association has been observed in specific study populations, such as Chinese heroin users, and reflects the role of the kappa-opioid receptor in opioid response. Please discuss any medication dosing or treatment adjustments with your clinician or pharmacist.
This is a common genotype, though exact frequency varies significantly by ancestral background.
Typical opioid response profile
There is currently limited evidence regarding the specific clinical impact of this heterozygous genotype on opioid response or stress-related addiction susceptibility. While the C allele has been linked to variations in methadone dosage, the functional consequences of carrying one T allele remain less clear. Please discuss your treatment plan and any concerns regarding medication response with your healthcare provider.
This genotype is found at varying frequencies across global populations, consistent with the common nature of this variant.
Typical opioid response profile
Current scientific literature does not provide a definitive clinical association for this specific homozygous genotype regarding addiction susceptibility or medication requirements. While the OPRK1 gene is involved in stress response and opioid signaling, the specific impact of the T/T genotype at this location is not well-characterized in existing studies. Always consult with your clinician or pharmacist regarding your medication management.
This genotype is observed in various populations, though it is less frequently highlighted in clinical association studies compared to the C allele.
Understanding the rs963549 Variant
The rs963549 variant is a single nucleotide polymorphism (SNP) located on chromosome 8. In the context of human genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant sits within the OPRK1 gene, which provides instructions for creating the kappa-opioid receptor. Because this variant is common, it is found frequently across diverse human populations. Scientists study such variants to understand how subtle differences in our genetic code might influence biological processes, such as how our bodies process certain medications or respond to environmental stressors. It is important to note that the presence of a specific genotype at this location does not determine a health outcome on its own, but rather serves as a point of interest for researchers investigating complex traits like addiction susceptibility and pharmacological response.
The Role of the OPRK1 Gene
The OPRK1 gene encodes the kappa-opioid receptor, a member of the G protein-coupled receptor family. These receptors are primarily located in the nervous system and play a critical role in modulating pain, mood, and stress responses. When activated by endogenous substances like dynorphins or by synthetic opioids, the kappa-opioid receptor triggers signaling pathways that can inhibit the release of neurotransmitters. Because of its involvement in these fundamental neurological pathways, the OPRK1 gene is a frequent subject of study in addiction medicine and pain management research. By influencing how the brain perceives and reacts to both internal signals and external substances, the kappa-opioid receptor system is thought to be a key player in the biological mechanisms underlying stress-related behaviors and the efficacy of opioid-based treatments.
Research Associations and Evidence Strength
Current research into rs963549 has primarily focused on its potential association with clinical outcomes in patients undergoing methadone treatment. Some studies have observed that specific genotypes, such as the C/C genotype, may be linked to lower daily maintenance doses of methadone among certain cohorts of heroin users. Additionally, other research has investigated whether variants in the kappa-opioid receptor gene contribute to individual differences in susceptibility to addiction, sometimes in conjunction with other genetic markers. However, the evidence strength for these associations remains limited. Many of these findings come from candidate gene studies, which are useful for generating hypotheses but often require larger, more diverse replication studies to confirm the clinical significance. Because these associations are often observed in specific populations, they may not be universally applicable, and the scientific community continues to evaluate the extent to which this variant influences real-world clinical outcomes.
Interpreting Your Genetic Information
If you have information about your rs963549 genotype, it is essential to understand that this data is for educational purposes only. Genetic variants like rs963549 are just one piece of a much larger puzzle that includes environmental factors, lifestyle, and other genetic influences. You cannot use this information to diagnose a condition or predict a personal response to medication. If you are currently taking methadone or any other medication, do not make any changes to your treatment plan based on genetic test results. Always discuss your medication dosage, treatment efficacy, and any concerns about side effects with your clinician or pharmacist. They are the only ones qualified to interpret your medical history and genetic information in the context of your overall health and to provide appropriate clinical guidance.
How common is this variant?
The rs963549 variant is considered a common SNP, meaning its genotypes are found at significant frequencies across various global populations.
Frequently asked questions
Can I use rs963549 to predict my response to methadone?
No. While some research has explored associations between this variant and methadone dosage, the evidence is limited and not sufficient for clinical decision-making. You should never adjust your medication based on genetic test results without consulting your doctor.
Is rs963549 a diagnostic test for addiction?
No. Addiction is a complex condition influenced by many genetic, environmental, and social factors. This variant is not a diagnostic tool and cannot determine if someone will develop an addiction.
Where can I find more information about OPRK1?
You can find reliable information about the OPRK1 gene and its functions through resources like the National Library of Medicine's MedlinePlus Genetics or the GeneCards database. These platforms provide comprehensive summaries of gene function and clinical relevance.
Why do studies show different results for this variant?
Genetic studies often show mixed results due to differences in study design, the size of the participant groups, and the ancestral backgrounds of the populations being studied. This is why scientific consensus requires multiple, large-scale replication studies.
Sources & further reading
Educational information only, last refreshed 9/25/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs963549?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29